Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

545 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New developments in the incretin concept.
Creutzfeldt W, Ebert R. Creutzfeldt W, et al. Diabetologia. 1985 Aug;28(8):565-73. doi: 10.1007/BF00281990. Diabetologia. 1985. PMID: 3902545 Review.
The [pre-] history of the incretin concept.
Creutzfeldt W. Creutzfeldt W. Regul Pept. 2005 Jun 15;128(2):87-91. doi: 10.1016/j.regpep.2004.08.004. Regul Pept. 2005. PMID: 15780427
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.
Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Nauck MA, et al. Among authors: creutzfeldt w. Diabetologia. 1993 Aug;36(8):741-4. doi: 10.1007/BF00401145. Diabetologia. 1993. PMID: 8405741 Clinical Trial.
In vivo metabolic action of insulin-like growth factor I in adult rats.
Schmitz F, Hartmann H, Stümpel F, Creutzfeldt W. Schmitz F, et al. Among authors: creutzfeldt w. Diabetologia. 1991 Mar;34(3):144-9. doi: 10.1007/BF00418267. Diabetologia. 1991. PMID: 1884885
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Nauck MA, et al. Among authors: creutzfeldt w. J Clin Endocrinol Metab. 1993 Apr;76(4):912-7. doi: 10.1210/jcem.76.4.8473405. J Clin Endocrinol Metab. 1993. PMID: 8473405 Clinical Trial.
Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
Siegel EG, Schulze A, Schmidt WE, Creutzfeldt W. Siegel EG, et al. Among authors: creutzfeldt w. Eur J Clin Invest. 1992 Mar;22(3):154-7. doi: 10.1111/j.1365-2362.1992.tb01820.x. Eur J Clin Invest. 1992. PMID: 1582439
Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.
Hartmann H, Oberhaus K, Spahr R, Brandenburg D, Creutzfeldt W, Probst I. Hartmann H, et al. Among authors: creutzfeldt w. Diabetologia. 1989 Jul;32(7):416-20. doi: 10.1007/BF00271260. Diabetologia. 1989. PMID: 2680697
Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content.
Siegel EG, Creutzfeldt W. Siegel EG, et al. Among authors: creutzfeldt w. Diabetologia. 1985 Nov;28(11):857-61. doi: 10.1007/BF00291078. Diabetologia. 1985. PMID: 2417905
Entero-insular axis and diabetes mellitus.
Creutzfeldt W. Creutzfeldt W. Horm Metab Res Suppl. 1992;26:13-8. Horm Metab Res Suppl. 1992. PMID: 1490680 Review.
Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Nauck MA, et al. Among authors: creutzfeldt w. Digestion. 1992;52(3-4):214-21. doi: 10.1159/000200956. Digestion. 1992. PMID: 1459356 Clinical Trial.
545 results
Jump to page
Feedback